According to reports from the National Medical Insurance Administration, the tenth batch of national organized Pharmaceutical procurement has produced proposed winning results, with 62 types of Pharmaceuticals successfully procured, all of which have expired patents, are produced by multiple companies, and have sufficient competition. A total of 385 products from 234 companies have obtained proposed selection qualifications, with an average of more than six companies bidding for each variety. Patients will be able to use the winning products at reduced prices from this procurement in April next year.